Riad Sherif
Chief Executive Officer at OCULIS HOLDING AG
Net worth: 10 M $ as of 29/04/2024
Riad Sherif active positions
Companies | Position | Start | End |
---|---|---|---|
REVENIO GROUP OYJ | Director/Board Member | 07/04/2022 | - |
Independent Dir/Board Member | 07/04/2022 | - | |
OCULIS HOLDING AG | Director/Board Member | 30/11/2017 | - |
Chief Executive Officer | 30/11/2017 | - | |
Investor Relations Contact | 30/11/2017 | - | |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Director/Board Member | - | - |
Chief Executive Officer | 31/12/2016 | - | |
XPND Medical SA | Chairman | 31/12/2015 | - |
Founder | 31/12/2015 | - |
Career history of Riad Sherif
Former positions of Riad Sherif
Companies | Position | Start | End |
---|---|---|---|
EURO BIOT | Director/Board Member | 27/02/2023 | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Sanofi-Aventis Algérie SpA | Corporate Officer/Principal | - | - |
Alcon Finland OY | Corporate Officer/Principal | - | - |
Statistics
International
Switzerland | 5 |
Finland | 3 |
United States | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 4 |
Commercial Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
REVENIO GROUP OYJ | Health Technology |
OCULIS HOLDING AG | Health Technology |
Private companies | 6 |
---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Alcon Finland OY | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Sanofi-Aventis Algérie SpA | |
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. Financial ConglomeratesFinance European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland. | Finance |
XPND Medical SA |
- Stock Market
- Insiders
- Riad Sherif
- Experience